Abstract
Vascular endothelial growth factor receptor-2, (VEGFR-2), is a key element in angiogenesis, the process by which new blood vessels are formed, and is thus an important pharmaceutical target. Here, 3-D quantitative structure–activity relationship (3-D QSAR) were used to build a quantitative screening and pharmacophore model of the VEGFR-2 receptors for design of inhibitors with improved activities. Most of available experimental data information has been used as training set to derive optimized and fully cross-validated eight mono-probe and a multi-probe quantitative models. Notable is the use of 262 molecules, aligned following both structure-based and ligand-based protocols, as external test set confirming the 3-D QSAR models’ predictive capability and their usefulness in design new VEGFR-2 inhibitors. From a survey on literature, this is the first generation of a wide-ranging computational medicinal chemistry application on VEGFR2 inhibitors.
Similar content being viewed by others
References
Ribatti D, Vacca A, Nico B, Roncali L, Dammacco F (2001) Mech Dev 100(2):157
Risau W (1997) Nature 386(6626):671
Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA (2004) Pharmacol Rev 56(4):549
Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, Pelletier N, Ferrara N (2001) J Biol Chem 276(5):3222
Arora A, Scholar EM (2005) J Pharmacol Exp Ther 315(3):971
Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) Nat Rev Mol Cell Biol 7(5):359
Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadburn A, Hyjek E, Gill M, Hicklin DJ, Witte L, Moore MA, Rafii S (2000) J Clin Invest 106(4):511
Almog N, Ma L, Raychowdhury R, Schwager C, Erber R, Short S, Hlatky L, Vajkoczy P, Huber PE, Folkman J, Abdollahi A (2009) Cancer Res 69(3):836
Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J (1972) J Exp Med 136(2):261
Posey JA, Ng TC, Yang B, Khazaeli MB, Carpenter MD, Fox F, Needle M, Waksal H, LoBuglio AF (2003) Clin Cancer Res 9(4):1323
Ferrara N, Hillan KJ, Gerber HP, Novotny W (2004) Nat Rev Drug Discov 3(5):391
Yakes FM, Chen J, Tan J, Yamaguchi K, Shi Y, Yu P, Qian F, Chu F, Bentzien F, Cancilla B, Orf J, You A, Laird AD, Engst S, Lee L, Lesch J, Chou YC, Joly AH (2011) Mol Cancer Ther 10(12):2298
Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R (2013) J Clin Oncol 31(2):181
Garofalo A, Goossens L, Six P, Lemoine A, Ravez S, Farce A, Depreux P (2011) Bioorg Med Chem Lett 21(7):2106
Hu E, Tasker A, White RD, Kunz RK, Human J, Chen N, Burli R, Hungate R, Novak P, Itano A, Zhang X, Yu V, Nguyen Y, Tudor Y, Plant M, Flynn S, Xu Y, Meagher KL, Whittington DA, Ng GY (2008) J Med Chem 51(11):3065
La DS, Belzile J, Bready JV, Coxon A, DeMelfi T, Doerr N, Estrada J, Flynn JC, Flynn SR, Graceffa RF, Harriman SP, Larrow JF, Long AM, Martin MW, Morrison MJ, Patel VF, Roveto PM, Wang L, Weiss MM, Whittington DA, Teffera Y, Zhao Z, Polverino AJ, Harmange JC (2008) J Med Chem 51(6):1695
Miyazaki Y, Matsunaga S, Tang J, Maeda Y, Nakano M, Philippe RJ, Shibahara M, Liu W, Sato H, Wang L, Nolte RT (2005) Bioorg Med Chem Lett 15(9):2203
Hodous BL, Geuns-Meyer SD, Hughes PE, Albrecht BK, Bellon S, Bready J, Caenepeel S, Cee VJ, Chaffee SC, Coxon A, Emery M, Fretland J, Gallant P, Gu Y, Hoffman D, Johnson RE, Kendall R, Kim JL, Long AM, Morrison M, Olivieri PR, Patel VF, Polverino A, Rose P, Tempest P, Wang L, Whittington DA, Zhao H (2007) J Med Chem 50(4):611
Harris PA, Boloor A, Cheung M, Kumar R, Crosby RM, Davis-Ward RG, Epperly AH, Hinkle KW, Hunter RN 3rd, Johnson JH, Knick VB, Laudeman CP, Luttrell DK, Mook RA, Nolte RT, Rudolph SK, Szewczyk JR, Truesdale AT, Veal JM, Wang L, Stafford JA (2008) J Med Chem 51(15):4632
Perspicace E, Jouan-Hureaux V, Ragno R, Ballante F, Sartini S, La Motta C, Da Settimo F, Chen B, Kirsch G, Schneider S, Faivre B, Hesse S (2013) Eur J Med Chem 63:765
Du J, Lei B, Qin J, Liu H, Yao X (2009) J Mol Graph Model 27(5):642
Jiang Q, Liao H, Yang Q, Zan W, Zang Z (2010) Mol Simul 36(9):693
Jiang X, Ou G, Yan D, Zhang M, Yuan X (2011) Lett Drug Des Discov 8(10):926
Kansal N, Silakari O, Ravikumar M (2008) Lett Drug Des Discov 5(7):437
Kar RK, Suryadevara P, Sahoo BR, Sahoo GC, Dikhit MR, Das P (2013) SAR QSAR Environ Res 24(3):215
Kumar Teli M, Hanumanthappa P, Krishnamurthy RG (2012) Lett Drug Des Discov 9(10):899
Lan P, Sun JR, Chen WN, Sun PH, Chen WM (2011) J Enzyme Inhib Med Chem 26(3):367
Lu X, Chen Y, You Q (2009) QSAR Comb Sci 28(11–12):1524
Munoz C, Adasme F, Alzate-Morales JH, Vergara-Jaque A, Kniess T, Caballero J (2012) J Mol Graph Model 32:39
Neaz M, Pasha F, Muddassar M, Lee SH, Sim T, Hah J-M, Cho SJ (2009) Med Chem Res 18(2):127
Pasha FA, Muddassar M, Neaz MM, Cho SJ (2009) J Mol Graph Model 28(1):54
Rajagopalan M, Balasubramanian S, Ramaswamy A, Mathur PP (2013) J Enzyme Inhib Med Chem 28(6):1236
Sharma BK, Sharma SK, Singh P, Sharma S (2008) J Enzyme Inhib Med Chem 23(2):168
Ugale VG, Patel HM, Surana SJ (2013) Arab J Chem 119
Wu X, Wu S, Chen WH (2012) J Mol Model 18(3):1207
Zeng H, Zhang H (2010) J Mol Graph Model 29(1):54
Zhang Y, Liu H, Jiao Y, Yuan H, Wang F, Lu S, Yao S, Ke Z, Tai W, Jiang Y, Chen Y, Lu T (2012) Mol Divers 16(4):787
Ballante F, Ragno R (2012) J Chem Inf Model 52(6):1674
Ballante F, Caroli A, Wickersham RB 3rd, Ragno R (2014) J Chem Inf Model 54(3):956
Ballante F, Tempera G, Agostinelli E, Ragno R (2013) Amino Acids 45(3):563
Friggeri L, Ballante F, Ragno R, Musmuca I, De Vita D, Manetti F, Biava M, Scipione L, Di Santo R, Costi R, Feroci M, Tortorella S (2013) J Chem Inf Model 53(6):1463
Caroli A, Ballante F, Wickersham RB 3rd, Corelli F, Ragno R (2014) J Chem Inf Model 54(3):970
Ragno R (2009) VEGFR-2 inhibitors. Ligand-based, structure-based and 3-D QSAR studies as tools to design new small molecules. XXIII Congresso Nazionale della Società Chimica Italiana. Sorrento, Italy
Berman HM, Bhat TN, Bourne PE, Feng Z, Gilliland G, Weissig H, Westbrook J (2000) Nat Struct Biol 7 Suppl:957
Musmuca I, Caroli A, Mai A, Kaushik-Basu N, Arora P, Ragno R (2010) J Chem Inf Model 50(4):662
Ragno R, Frasca S, Manetti F, Brizzi A, Massa S (2005) J Med Chem 48(1):200
Castellano S, Stefancich G, Ragno R, Schewe K, Santoriello M, Caroli A, Hartmann RW, Sbardella G (2008) Bioorg Med Chem 16(18):8349
Jain AN (2004) J Med Chem 47(4):947
OpenEye Scientific Software SF, NM. OMEGA 2.5.1.4
Hawkins PC, Skillman AG, Warren GL, Ellingson BA, Stahl MT (2010) J Chem Inf Model 50(4):572
OpenEye Scientific Software SF, NM. ROCS. 3.2.0.4
Hawkins PC, Skillman AG, Nicholls A (2007) J Med Chem 50(1):74
Vainio MJ, Johnson MS (2007) J Chem Inf Model 47(6):2462
Puranen JS, Vainio MJ, Johnson MS (2010) J Comput Chem 31(8):1722
Vainio MJ, Puranen JS, Johnson MS (2009) J Chem Inf Model 49(2):492
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) J Comput Chem 30(16):2785
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) J Comput Chem 25(13):1605
Yuriev E, Ramsland PA (2013) J Mol Recognit 26(5):215
O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) J Cheminform 3:33
Wold S, Johansson E, Cocchi M (1993) PLS: partial least squares projections to latent structures in 3D QSAR in drug design: theory, methods and applications. ESCOM Science Publishers
Xia Y, Song X, Li D, Ye T, Xu Y, Lin H, Meng N, Li G, Deng S, Zhang S, Liu L, Zhu Y, Zeng J, Lei Q, Pan Y, Wei Y, Zhao Y, Yu L (2014) Sci Rep 4:6031
Acknowledgments
E.P. thanks MESR for Ph.D. grant.
Funding
This study was funded by Italian Minister of University and Research (MIUR) (PRIN Grant. 20105YY2HL_003 and FIRB Grant RBFR10ZJQT).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ragno, R., Ballante, F., Pirolli, A. et al. Vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors: development and validation of predictive 3-D QSAR models through extensive ligand- and structure-based approaches. J Comput Aided Mol Des 29, 757–776 (2015). https://doi.org/10.1007/s10822-015-9859-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-015-9859-y